Further studies are warranted to explore unresolved issues, including the expression of SATB2 in EMPD from non-perianal sites and the diagnostic performance of NKX3.1 in prostatic secondary EMPD. The gene discussed is NKX3-1; the disease is extramammary Paget disease.